These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 8113866)
21. Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005. Ji Y; Rankin C; Grunberg S; Sherrod AE; Ahmadi J; Townsend JJ; Feun LG; Fredericks RK; Russell CA; Kabbinavar FF; Stelzer KJ; Schott A; Verschraegen C J Clin Oncol; 2015 Dec; 33(34):4093-8. PubMed ID: 26527781 [TBL] [Abstract][Full Text] [Related]
22. Toll-like receptor-4 is expressed in meningiomas and mediates the antiproliferative action of paclitaxel. Tichomirowa MA; Theodoropoulou M; Daly AF; Yassouridis A; Hansen S; Lu J; Lange M; Goldbrunner RH; Stalla GK; Renner U Int J Cancer; 2008 Oct; 123(8):1956-63. PubMed ID: 18688857 [TBL] [Abstract][Full Text] [Related]
23. Effect of systemic celecoxib on human meningioma after intracranial transplantation into nude mice. Friedrich S; Schwabe K; Grote M; Krauss JK; Nakamura M Acta Neurochir (Wien); 2013 Jan; 155(1):173-82. PubMed ID: 23143216 [TBL] [Abstract][Full Text] [Related]
24. Hormonotherapy of meningiomas with medroxyprogesterone acetate. Immunohistochemical demonstration of the effect of medroxyprogesterone acetate on growth fractions of meningioma cells using the monoclonal antibody Ki-67. Markwalder TM; Gerber HA; Waelti E; Schaffner T; Markwalder RV Surg Neurol; 1988 Aug; 30(2):97-101. PubMed ID: 2969629 [TBL] [Abstract][Full Text] [Related]
25. The Role of Mifepristone in Meningiomas Management: A Systematic Review of the Literature. Cossu G; Levivier M; Daniel RT; Messerer M Biomed Res Int; 2015; 2015():267831. PubMed ID: 26146614 [TBL] [Abstract][Full Text] [Related]
26. Effect of antiprogestins and tamoxifen on growth inhibition of MCF-7 human breast cancer cells in nude mice. El Etreby MF; Liang Y Breast Cancer Res Treat; 1998 May; 49(2):109-17. PubMed ID: 9696393 [TBL] [Abstract][Full Text] [Related]
27. Modulation of meningioma cell growth by sex steroid hormones in vitro. Jay JR; MacLaughlin DT; Riley KR; Martuza RL J Neurosurg; 1985 May; 62(5):757-62. PubMed ID: 3989596 [TBL] [Abstract][Full Text] [Related]
28. Detection of progesterone receptor and the correlation with Ki-67 labeling index in meningiomas. Mukherjee S; Ghosh SN; Chatterjee U; Chatterjee S Neurol India; 2011; 59(6):817-22. PubMed ID: 22234191 [TBL] [Abstract][Full Text] [Related]
30. RAS Promotes Proliferation and Resistances to Apoptosis in Meningioma. Jiang C; Song T; Li J; Ao F; Gong X; Lu Y; Zhang C; Chen L; Liu Y; He H; Huang O Mol Neurobiol; 2017 Jan; 54(1):779-787. PubMed ID: 27021020 [TBL] [Abstract][Full Text] [Related]
31. Clinical and histological features of multiple meningiomas compared with solitary meningiomas. Huang H; Buhl R; Hugo HH; Mehdorn HM Neurol Res; 2005 Apr; 27(3):324-32. PubMed ID: 15845217 [TBL] [Abstract][Full Text] [Related]
32. Oestrogen and progesterone sensitivity in cultured meningioma cells. Maiuri F; Montagnani S; Gallicchio B; Carandente M; Lanza GG; D'Andrea F Neurol Res; 1989 Mar; 11(1):9-13. PubMed ID: 2565555 [TBL] [Abstract][Full Text] [Related]
33. Occurrence, regulation, and significance of progesterone receptors in human meningioma. Blankenstein MA; Verheijen FM; Jacobs JM; Donker TH; van Duijnhoven MW; Thijssen JH Steroids; 2000; 65(10-11):795-800. PubMed ID: 11108890 [TBL] [Abstract][Full Text] [Related]
34. Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression. Abdelzaher E; El-Gendi SM; Yehya A; Gowil AG Br J Neurosurg; 2011 Dec; 25(6):707-13. PubMed ID: 20979437 [TBL] [Abstract][Full Text] [Related]
38. The tumour-inhibiting potential of the progesterone antagonist Onapristone in the human mammary carcinoma T61 in nude mice. Schneider MR; Michna H; Habenicht UF; Nishino Y; Grill HJ; Pollow K J Cancer Res Clin Oncol; 1992; 118(3):187-9. PubMed ID: 1548283 [TBL] [Abstract][Full Text] [Related]
39. Expression of progestrone receptor and proliferative marker ki 67 in various grades of meningioma. Shayanfar N; Mashayekh M; Mohammadpour M Acta Med Iran; 2010; 48(3):142-7. PubMed ID: 21137648 [TBL] [Abstract][Full Text] [Related]
40. Proliferation and progesterone receptor status in benign meningiomas are not age dependent. Roser F; Nakamura M; Ritz R; Bellinzona M; Dietz K; Samii M; Tatagiba MS Cancer; 2005 Aug; 104(3):598-601. PubMed ID: 15952201 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]